Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8211481 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 39 Pages |
Abstract
The OS of matched patients with stage II-IVA GBC is significantly improved by CCRT. Radiation therapy combined with single-agent or dual-agent chemotherapy was feasible and well tolerated.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Benxing MD, Liwen MD, Hong MD, Jianbin MD, Qi MD, Jingjing MD, Liming MD, Hai MD, Qichu MD, Xiao MD, Xiujun MD, PhD, Xiaonan MD, PhD,